After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
UroGen Pharma Ltd is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of UroGen Pharma Ltd is $495.97M. A total of 0.98 million shares were traded on the day, compared to an average of 460.75K shares.
In the most recent transaction, Schoenberg Mark sold 4,551 shares of URGN for 11.14 per share on Jan 31 ’25. After the transaction, the Chief Medical Officer now owns 145,666 company shares. In a previous transaction on Jan 31 ’25, Smith Jason Drew sold 7,379 shares at 11.14 per share. URGN shares that General Counsel owns now total 26,468.
Among the insiders who sold shares, Schoenberg Mark disposed of 859 shares on Sep 09 ’24 at a per-share price of $13.08. This resulted in the Chief Medical Officer holding 145,091 shares of URGN after the transaction. In another insider transaction, Smith Jason Drew sold 1,521 shares at $13.08 per share on Sep 09 ’24. Company shares held by the General Counsel now total 25,226.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, URGN has a high of $20.70 and a low of $8.94.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. URGN’s latest balance sheet shows that the firm has $89.14M in Cash & Short Term Investments as of fiscal 2021. There were $398.00k in debt and $22.38M in liabilities at the time. Its Book Value Per Share was -$0.21, while its Total Shareholder’s Equity was $8.41M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for URGN is Buy with a score of 4.75.
